Daniel Cox, MD
Vascular Surgery · O'Fallon, ILNPI 1205862117
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 21 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Shockwave Medical, Inc at 44.8% of the total. Reporting peaked in 2024 at $196 and has fallen 77.1% since, to $45 in 2025. That places this record below the midpoint for vascular surgery clinicians in IL, where the typical reported total is $4,613.
Across 21 payments — averaging $15.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$149
- W. L. Gore & Associates, Inc.$74
- Elutia, Inc.$24
- Abbott$22
- Kestra Medical Technology Services, Inc.$19
- Cardiovascular Systems Inc.$19
- plus $27 from 2 others
What the payments were for
- Food & beverage$332100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 13 | $149 |
| W. L. Gore & Associates, Inc. | 2 | $74 |
| Elutia, Inc. | 1 | $24 |
| Abbott | 1 | $22 |
| Kestra Medical Technology Services, Inc. | 1 | $19 |
| Cardiovascular Systems Inc. | 1 | $19 |
| Medtronic | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $10 |
How this compares
$332 in reported general payments places this provider in the 15th percentile of 170 vascular surgery providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $8,401 |
| Cilostazol | 38 | $736 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 72 | $349 |
| Doxycycline Hyclate | 13 | $289 |
| ClopidogrelClopidogrel Bisulfate | 45 | $204 |
| Cephalexin | 14 | $91 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in O'Fallon
- Ross MilnerChicago$1.3M
- Sapan DesaiArlington Heights$1.2M
- Nabeel RanaPeoria$934K
- Atif BaqaiPark Ridge$567K
- Trissa BabrowskiChicago$292K
- Tejas ShahDowners Grove$213K
- Carlos BecharaMaywood$199K
- Dhiren PatelSpringfield$121K
- Heron RodriguezChicago$105K
- Michael SoultMaywood$104K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.